Citizens initiates Klarna stock coverage at Market Perform

Citizens initiated coverage on Klarna (KLAR) with a Market Perform rating, noting competitive pressure in its Pay-in-X underwriting and limited in-house underwriting capabilities that raise credit-risk concerns. Klarna trades around $20.24 (down 56% from $57.20 52-week high) while showing continued cash burn and loss-making over the last 12 months, though analysts expect it to turn profitable this year; Citizens also flagged pending IP/underwriting litigation from Pagaya. On the business side, Klarna launched U.S. savings accounts with rates starting at 3.28% APY and expanded payment partnerships (e.g., Ulta Beauty; Lands’ End via Stripe), while Freedom Capital started KLAR as Buy and BMO lifted its target to $19 from $17.

Analysis

The market should treat this as a valuation reset for BNPL, not a one-off analyst call. The core issue is that growth in installment lending is only valuable if marginal credit losses and funding costs stay below merchant take-rate expansion; once the model requires longer-dated receivables, equity value becomes highly sensitive to small changes in loss assumptions and delinquency seasoning. That makes KLAR’s upside path less about transaction volume and more about whether it can prove a lower-cost underwriting edge than AFRM.

Near term, the real catalyst is not partnerships but disclosure quality over the next 1-3 months: mix shift, charge-off trends, and whether U.S. expansion needs more balance-sheet support than currently assumed. The litigation over underwriting/IP matters because it could slow partner wins and make merchants more cautious about exclusivity or renewal terms, which is a second-order drag on growth even if headline GMV holds up. If funding costs stay elevated, the longer-duration credit book becomes a spread compression story, not a scale story.

Contrarian view: the consensus may be focusing too much on top-line growth and too little on survivability of the economics. If Klarna proves profitable, that may still not justify a premium multiple because competition makes the moat shallow; if it misses, downside can be abrupt because cash burn and credit risk compound. Relative value favors the cleaner credit narrative over the weaker one, but only if the next print confirms underwriting stability; otherwise the entire sector can re-rate lower together.

Key Decisions for Investors

• Short KLAR / long AFRM as a 1-3 month relative-value trade: thesis is that credit scrutiny and funding needs compress KLAR’s multiple faster than AFRM’s, with the pair insulated from broad fintech beta. Falsify if KLAR shows materially better delinquency trends and raises guidance without incremental capital needs.
• Do not chase ULTA or LE on the payment-partnership headlines; any conversion lift is likely too small to move enterprise value versus the lender’s credit risk. Treat merchant names as watch items only unless checkout adoption data shows material share shift over the next quarter.
• Set a litigation alert on PGY rather than a directional trade today: the optionality is real only if discovery validates underwriting/IP claims or settlement economics become visible. Without that, the stock is likely a noisy catalyst trade, not a fundamentals trade.